Minerva Neurosciences | NERV - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Acadia Pharmaceuticals USD 4.53B 199M 2026-08
Adma Biologics USD 2.15B 2.19B 2026-03
ALKERMES USD 7.93B 806M 2026-08
Alterity Therapeutics Limited AUD 39M 17M 2026-08
AstraZeneca USD 178.16B 111.83B 2026-08
BioCryst Pharmaceuticals USD 1.9B 643M 2026-08
Bristol-Myers Squibb USD 117.66B 6.17B 2026-06
Cipla INR 1.18T 194.93B 2026-06
Clal Biotechnology ILS 43.45M 8.92M 2026-03
Compugen USD 620.29M 475.62M 2026-03
CSL USD 60.19B 4.3B 2026-08
Eli Lilly USD 1.11T 18.32B 2026-08
GlaxoSmithKline GBP 80.14B 3.66B 2026-06
Halozyme Therapeutics USD 10.91B 1.63B 2026-08
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
J&J USD 611.36B 32.21B 2026-06
Merck USD 324.18B 6.81B 2026-08
Neurocrine Biosciences USD 16.95B 3.7B 2026-06
Novartis USD 240.59B 67.17B 2026-06
Novavax USD 1.09B 316M 2025-12
Pfizer USD 153.17B 14.73B 2026-08
Roche Holding CHF 270B 3.66B 2026-06
Sanofi EUR 91.15B 9.12B 2026-06
Takeda JPY 8.2T 809.7B 2026-06
Vanda Pharmaceuticals USD 279M 6M 2024-12